Ardelyx (ARDX) Property, Plant & Equipment (Net) (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.33% |
| Dec 31, 2025 | 5.56% |
| Sep 30, 2025 | -3.45% |
| Jun 30, 2025 | 28.71% |
| Mar 31, 2025 | 11.37% |
| Dec 31, 2024 | 45.43% |
| Sep 30, 2024 | 1.18% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | 0.99% |
| Dec 31, 2023 | -9.59% |
| Sep 30, 2023 | 4.89% |
| Jun 30, 2023 | -3.45% |
| Mar 31, 2023 | -9.89% |
| Dec 31, 2022 | -5.49% |
| Sep 30, 2022 | -16.03% |
| Jun 30, 2022 | -24.65% |
| Mar 31, 2022 | -13.42% |
| Dec 31, 2021 | -10.90% |
| Sep 30, 2021 | -0.56% |
| Jun 30, 2021 | 16.32% |
| Mar 31, 2021 | 18.39% |
| Dec 31, 2020 | -8.29% |
| Sep 30, 2020 | -15.59% |
| Jun 30, 2020 | -15.73% |
| Mar 31, 2020 | -13.62% |
| Dec 31, 2019 | -12.86% |
| Sep 30, 2019 | -11.77% |
| Jun 30, 2019 | -12.41% |
| Mar 31, 2019 | -9.07% |
| Dec 31, 2018 | -6.42% |
| Sep 30, 2018 | -10.36% |
| Jun 30, 2018 | -9.09% |
| Mar 31, 2018 | -8.39% |
| Dec 31, 2017 | -6.84% |
| Sep 30, 2017 | -7.64% |
| Jun 30, 2017 | 4.71% |
| Mar 31, 2017 | -0.85% |
| Dec 31, 2016 | 29.01% |
| Sep 30, 2016 | 44.38% |
| Jun 30, 2016 | 5.00% |
| Mar 31, 2016 | -2.42% |
| Dec 31, 2015 | 7.29% |
| Sep 30, 2015 | 8.13% |
| Jun 30, 2015 | 23.47% |
| Mar 31, 2015 | 54.34% |
| Dec 31, 2014 | 84.98% |
| Sep 30, 2014 | 1.23% |